Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Merck & Co (NY: MRK)
85.98 USD  -2.58 (-2.91%)
Official Closing Price  /  Updated: 7:59 PM EST, Jan 24, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 14,270,200
Open 88.63
Bid (Size) 85.00 (1)
Ask (Size) 89.98 (10)
Prev. Close 88.56
Today's Range 85.58 - 88.83
52wk Range 72.05 - 92.64
Shares Outstanding 2,690,303,898
Dividend Yield 2.23%
Performance
YTD
-6.58%
-6.58%
1 Month
-5.87%
-5.87%
3 Month
+4.60%
+4.60%
6 Month
+4.23%
+4.23%
1 Year
+17.86%
+17.86%
Top News
More News
Health Canada Approves KEYTRUDA® (pembrolizumab) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma (RCC)
from PR Newswire
Koneksa Health Announces Study Publication Validating mHealth Technologies in Early-Stage Clinical Trial Safety Monitoring
Wearable Devices Accurately Measure Heart Rate and Blood Pressure to Detect Drug Treatment Effects Read More
from PR Newswire
More News
Read More
BriaCell Invited to Present at Mount Sinai’s Frontiers in Academic Pathology Symposium at The New York Academy of Medicine
from GlobeNewswire News Releases
FDA Accepts Regulatory Submission of Supplemental New Drug Application for LYNPARZA® (olaparib) in HRR-Mutated Metastatic Castration-Resistant Prostate Cancer and Grants Priority Review
from Business Wire News Releases
Significant Study on Veterinary Wellbeing Reveals Importance of Continued Focus on Personal and Professional Health and Wellbeing Among Veterinarians
from PR Newswire
UPDATE 3-U.S. health officials confirm second U.S. case of Wuhan coronavirus
category companyNews
from Reuters: Company News
Noteworthy ETF Inflows: VHT, UNH, MRK, CVS
category ETFs
from ETF Channel
Roche's Tecentriq Fails to Help Patients in Muscle-Invasive Bladder Cancer Trial
category RHHBY , Market News , MRK
from Motley Fool
Should Investors Be Worried About Merck's Keytruda?
category BMY , Market News , BGNE , and 3 more.
from Motley Fool
5 Big Drug/Biotech Stocks Set To Trump Q4 Earnings Estimates
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings
category EPZM , FTSV , MRK , and 15 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.